Clinical Trial Update: EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating extended pre-quit varenicline (EVarQuit) to aid in quitting smoking; results were posted in July 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Tobacco Smoking | Phase 3 | Status: COMPLETED | Results posted: 2023-07-11